Horm Metab Res 2004; 36(5): 307-311
DOI: 10.1055/s-2004-814491
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

Dependency of the Metabolic Effect of sc-Injected Human Regular Insulin on Intra-abdominal Fat in Patients with Type 2 Diabetes

K.  Rave1 , L.  Nosek1 , L.  Heinemann1 , A.  Frick2 , R.  Becker2 , C.  Kapitza1
  • 1Profil Institute for Metabolic Research, Neuss, Germany
  • 2Aventis Pharma Deutschland, Frankfurt/M, Germany
Further Information

Publication History

Received 4 September 2003

Accepted after Revision 11 November 2003

Publication Date:
24 May 2004 (online)

Abstract

Ten patients with type 2 diabetes were enrolled in an isoglycemic glucose clamp study to determine the impact of intra-abdominal fat, subcutaneous abdominal fat and total abdominal fat on the metabolic effect of a single bolus (0.2 IU/kg) of sc-injected human regular insulin. The maximum metabolic effect associated highly and negatively with intra-abdominal fat (r = - 0.72, p < 0.02) and with the homeostasis model assessment insulin resistance score (HOMA, r = - 0.71, p < 0.03). Likewise, the total metabolic effect of sc-injected insulin correlated strongly and negatively with intra-abdominal fat (r = - 0.77, p < 0.01), HOMA (r = - 0.74, p < 0.02) and HbA1c (r = - 0.70, p < 0.03). Stepwise multiple regression analyses showed that the highest metabolic effect was only significantly predicted by intra-abdominal fat, indicating a high negative correlation with the maximum effect (β = - 0.72) whereas time to maximum metabolic effect showed a strong (β = 0.72) and positive correlation with HOMA. In combination with the HOMA, it is intra-abdominal fat, and not subcutaneous abdominal fat, which explains 50 - 75 % of the variability of the effect of sc human regular insulin in patients with type 2 diabetes.

References

  • 1 Yamashita S, Nakamura T, Shimomura I, Nishida M, Yoshida S, Kotani K, Kameda-Takemuara K, Tokunaga K, Matsuzawa Y. Insulin resistance and body fat distribution.  Diab Care. 1996;  19 287-291
  • 2 Hernandez-Ono A, Monter-Carreola G, Zamora-Gonzalez J, Cardoso-Saldana G, Posadas-Sanchez R, Torres-Tamayo M, Posadas-Romero C. Association of visceral fat with coronary risk factors in a population-based sample of postmenopausal women.  Int J Obes Relat Metab Disord. 2002;  26 33-39
  • 3 Brochu M, Starling R D, Tchernof A, Matthews D E, Garcia-Rubi E, Poehlman E T. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women.  J Clin Endocrinol Metab. 2000;  85 2378-2384
  • 4 Banerji M A, Faridi N, Atluri R, Chaiken R L, Lebovitz H E. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.  J Clin Endocrinol Metab. 1999;  84 137-144
  • 5 Atzmon G, Yang X M, Muzumdar R, Ma X H, Gabriely I, Barzilai N. Differential gene expression between visceral and subcutaneous fat depots.  Horm Metab Res. 2002;  34 622-628
  • 6  . Report of the Expert Committee on the Diagnosisand Classification of Diabetes Mellitus.  Diab Care. 1998;  21 5-19
  • 7 Poll L W, Wittsack H J, Koch J A, Willers R, Scherer A, Kapitza C, Heinemann L, Modder U. Quantification of total abdominal fat volumes using magnetic resonance imaging.  Eur J Med Res. 2002;  7 347-352
  • 8 Lancaster J L, Ghiatas A A, Alyassin A, Kilcoyne R F, Bonora E, DeFronzo R A. Measurement of abdominal fat with T1-weighted MR images.  J Magn Reson Imaging. 1991;  1 363-369
  • 9 Durnin J V, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.  Br J Nutr. 1974;  32 77-97
  • 10 Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
  • 11 Rave K, Heise T, Pfutzner A, Heinemann L, Sawicki P T. Impact of diabetic nephropathy on pharmacodynamic and pharmacokinetic properties of insulin in type 1 diabetic patients.  Diabetes Care. 2001;  24 886-890
  • 12 Ross R, Dagnone D, Jones P J, Smith H, Paddags A, Hudson R, Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial.  Ann Intern Med. 2000;  133 92-103
  • 13 Vora J P, Burch A, Peters J R, Owens D R. Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry.  Diab Care. 1992;  15 1484-1493
  • 14 Sjostrand M, Gudbjornsdottir S, Holmang A, Lonn L, Strindberg L, Lonnroth P. Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects.  Diab. 2002;  51 2742-2748
  • 15 Caprio S, Hyman L D, Limb C, McCarthy S, Lange R, Sherwin R S, Shulman G, Tamborlane W V. Central adiposity and its metabolic correlates in obese adolescent girls.  Am J Physiol. 1995;  269 E118-E126
  • 16 Gautier J F, Mourier A, de Kerviler E, Tarentola A, Bigard A X, Villette J M, Guezennec C Y, Cathelineau G. Evaluation of abdominal fat distribution in noninsulin-dependent diabetes mellitus: relationship to insulin resistance.  J Clin Endocrinol Metab. 1998;  83 1306-1311
  • 17 Carey D G, Jenkins A B, Campbell L V, Freund J, Chisholm D J. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.  Diab. 1996;  45 633-638
  • 18 Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, DeFronzo R A, Ferrannini E. Metabolic effects of visceral fat accumulation in type 2 diabetes.  J Clin Endocrinol Metab. 2002;  87 5098-5103
  • 19 Goodpaster B H, Thaete F L, Simoneau J A, Kelley D E. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.  Diab. 1997;  46 1579-1585
  • 20 Park K S, Rhee B D, Lee K U, Kim S Y, Lee H K, Koh C S, Min H K. Intra-abdominal fat is associated with decreased insulin sensitivity in healthy young men.  Metabolism. 1991;  40 600-603
  • 21 Abate N, Garg A, Peshock R M, Stray-Gundersen J, Grundy S M. Relationships of generalized and regional adiposity to insulin sensitivity in men.  J Clin Invest. 1995;  96 88-98
  • 22 Lovejoy J C, de la Bretonne J A, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race.  Metabolism. 1996;  45 1119-1124
  • 23 Gautier J F, Milner M R, Elam E, Chen K, Ravussin E, Pratley R E. Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion.  Diabetologia. 1999;  42 28-34
  • 24 Thomas E L, Saeed N, Hajnal J V, Brynes A, Goldstone A P, Frost G, Bell J D. Magnetic resonance imaging of total body fat.  J Appl Physiol. 1998;  85 1778-1785
  • 25 Shen W, Wang Z, Punyanita M, Lei J, Sinav A, Kral J G, Imielinska C, Ross R, Heymsfield S B. Adipose tissue quantification by imaging methods: a proposed classification.  Obes Res. 2003;  11 5-16

K. Rave, M. D.

Profil Institute for Metabolic Research

Hellersbergstr. 9 · 41460 Neuss · Germany ·

Phone: +49(2131)4018-403

Fax: +49(2131)4018-503

Email: klaus.rave@profil-research.de

    >